What Investors Ought To Know About MindMed In 2025
[embedded content] TDR Top 3 takeaways from the video on MindMed’s announcements, and plans for 2025: MindMed achieved a significant milestone in 2024 by dosing
[embedded content] TDR Top 3 takeaways from the video on MindMed’s announcements, and plans for 2025: MindMed achieved a significant milestone in 2024 by dosing
Happy Black Friday, and in this special Trade To Black episode, Melissa Lavasani, CEO of Psychedelic Medicine, and former Top Gun Fighter Pilot Matthew “Whiz”
On our latest Trade To Black Podcast, we’re going to take a look at Cybin’s psychedelic breakthroughs with CYB003 with CEO Doug Drysdale, Eaze Technologies’
SUNNYVALE, Calif., Aug. 12, 2024 /CNW/ – Willow Biosciences Inc. (“Willow” or the “Company”) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing
Numinus Wellness Inc. (TSX:NUMI), a mental health care specializing in innovative treatments, recently commented on the FDA’s decision regarding Lykos Therapeutics’ new drug application for
Healing Realty Trust (HRT), a data-driven, self-managed real estate investment trust (REIT) focusing on healthcare-related properties, has recently entered into Preferred Real Estate Partnership Agreements
Eighty members of Congress from both parties have come together to send letters to President Joe Biden and the US Food and Drug Administration, urging
Every day, between 22 and 44 veterans take their own lives by suicide or other means, says Matthew ‘Whiz’ Buckley. “That’s a shooting. A mass
In this episode of the Trade to Black Podcast, we pivot back to psychedelics, where the company Cybin has enjoyed three big pieces of news
On today’s episode of TDR’s Trade To Black podcast, we’re back with another psychedelics exclusive. In today’s interview, we’re joined by Payton Nyquvest, Founder and